JF
Therapeutic Areas
Tarsus Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| XDEMVY (TP-03) | Demodex Blepharitis | Commercial |
| TP-03 | Meibomian Gland Disease (MGD) | Phase 2b |
| TP-04 | Ocular Rosacea | Phase 2 |
| TP-05 | Lyme Disease Prevention | Phase 1 |
| Drug | Indication | Phase |
|---|---|---|
| XDEMVY (TP-03) | Demodex Blepharitis | Commercial |
| TP-03 | Meibomian Gland Disease (MGD) | Phase 2b |
| TP-04 | Ocular Rosacea | Phase 2 |
| TP-05 | Lyme Disease Prevention | Phase 1 |